Digestive Diseases and Sciences

, Volume 57, Issue 3, pp 786–790 | Cite as

Metallic or Plastic Stent for Bile Duct Obstruction in Ampullary Cancer?

  • Su Bum Park
  • Hyung Wook Kim
  • Dae Hwan Kang
  • Cheol Woong Choi
  • Je Ho Ryu
  • Chong Woo Chu
  • Soo Yong Lee
  • Young Il Jeong
  • Hye Ju Yeo
  • Eun Jung Kim
Original Article


Background and Aims

Although ampullary cancer is a relatively uncommon malignancy, it is frequently associated with biliary obstruction. Endoscopic biliary drainage is regarded as a palliative treatment of choice for patients with inoperable ampullary cancer. However, there are no data concerning choice of stent in this patient population. The objective of this study was to compare the efficacy of metallic and plastic stents for biliary obstruction in patients with ampullary cancer.


Thirty-seven patients (15 men and 22 women; median age 74.7 years) with ampullary cancer treated with endoscopic biliary drainage were enrolled. Metallic and two plastic stents were placed in 17 and 20 patients, respectively. Clinical success, stent patency, and stent malfunction were evaluated.


Clinical success was achieved in all patients (100%). The median period of stent patency was 132.7 days in the metallic stent group and 128.5 days in the plastic stent group (P > 0.05). Stent malfunctions developed in 17 and 19 patients in the metallic and plastic stent groups, respectively. Stent occlusion occurred in 15 (88.2%) and 15 (75%) patients and stent migration occurred in two (11.8%) and four (20%) patients in the metallic and plastic stent groups, respectively.


Endoscopic biliary drainage using metallic or plastic stents is effective for initial endoscopic palliation in patients with obstructive jaundice because of ampullary cancer. Although metallic and plastic stents had similar clinical effect, it seems reasonable to choose two plastic stents as the first option in patients with ampullary cancer considering the cost-effectiveness.


Ampullary cancer Stent Biliary obstruction 



This study was supported by a grant from the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A091047).

Conflicts of interest

S. B. Park, H. W. Kim, D. H. Kang, C. W. Choi, J. H. Ryu, C. W. Chu, S. Y. Lee, Y. I. Jeong, H. J. Yeo, and E. J. Kim have no conflicts of interest or financial ties to disclose.


  1. 1.
    Conlon KC. Carcinoma of the ampulla of vater: a distinct disease entity? Ann Surg Oncol. 2003;10:1136–1137.PubMedCrossRefGoogle Scholar
  2. 2.
    Talamini MA, Moesinger RC, Pitt HA, et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg. 1997;225:590–599. Discussion 599–600.PubMedCrossRefGoogle Scholar
  3. 3.
    Albores-Saavedra J, Schwartz AM, Batich K, Henson DE. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5, 625 cases from the SEER program. J Surg Oncol. 2009;100:598–605.PubMedCrossRefGoogle Scholar
  4. 4.
    Qiao QL, Zhao YG, Ye ML, et al. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg. 2007;31:137–143. Discussion 144–146.PubMedCrossRefGoogle Scholar
  5. 5.
    Sivak MV. Clinical and endoscopic aspects of tumors of the ampulla of Vater. Endoscopy. 1988;20:211–217.PubMedCrossRefGoogle Scholar
  6. 6.
    Morris-Stiff G, Alabraba E, Tan YM, et al. Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology. Eur J Surg Oncol. 2009;35:746–750.PubMedCrossRefGoogle Scholar
  7. 7.
    Woo SM, Ryu JK, Lee SH, et al. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol. 2007;14:3195–3201.PubMedCrossRefGoogle Scholar
  8. 8.
    Sarmiento JM, Nagomey DM, Sarr MG, Farnell MB. Periampullary cancers: are there differences? Surg Clin North Am. 2001;81:543–555.PubMedCrossRefGoogle Scholar
  9. 9.
    Heinrich S, Clavien PA. Ampullary cancer. Curr Opin Gastroenterol. 2010;26:280–285.PubMedCrossRefGoogle Scholar
  10. 10.
    McLean GK, Burke DR. Role of endoprostheses in the management of malignant biliary obstruction. Radiology. 1989;170:961–967.PubMedGoogle Scholar
  11. 11.
    Adler DG, Baron TH, Davila RE, et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2005;62:1–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Speer AG, Cotton PB, Russell RC, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet. 1987;2:57–62.PubMedCrossRefGoogle Scholar
  13. 13.
    Prat F, Chapat O, Ducot B, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc. 1998;47:1–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Hammarstrom LE. Role of palliative endoscopic drainage in patients with malignant biliary obstruction. Dig Surg. 2005;22:295–304. discussion 305.PubMedCrossRefGoogle Scholar
  15. 15.
    Cotton PB. Duodenoscopic placement of biliary prostheses to relieve malignant obstructive jaundice. Br J Surg. 1982;69:501–503.PubMedCrossRefGoogle Scholar
  16. 16.
    Huibregtse K, Haverkamp HJ, Tytgat GN. Transpapillary positioning of a large 3.2 mm biliary endoprosthesis. Endoscopy. 1981;13:217–219.PubMedCrossRefGoogle Scholar
  17. 17.
    Zimmon DS, Chang J, Clemett AR. Advances in the management of bile duct obstruction: percutaneous transhepatic cholangiography and endoscopic retrograde cholangiopancreatography. Med Clin North Am. 1979;63:593–609.PubMedGoogle Scholar
  18. 18.
    Cairns SR, Dias L, Cotton PB, Salmon PR, Russell RC. Additional endoscopic procedures instead of urgent surgery for retained common bile duct stones. Gut. 1989;30:535–540.PubMedCrossRefGoogle Scholar
  19. 19.
    Weber A, Mittermeyer T, Wagenpfeil S, Schmid RM, Prinz C. Self-expanding metal stents versus polyethylene stents for palliative treatment in patients with advanced pancreatic cancer. Pancreas. 2009;38:e7–e12.PubMedCrossRefGoogle Scholar
  20. 20.
    Lammer J, Hausegger KA, Fluckiger F, et al. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology. 1996;201:167–172.PubMedGoogle Scholar
  21. 21.
    Kullman E, Frozanpor F, Soderlund C, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 2010;72:924–926.CrossRefGoogle Scholar
  22. 22.
    Johanson JF, Schmalz MJ, Geenen JE. Incidence and risk factors for biliary and pancreatic stent migration. Gastrointest Endosc. 1992;38:341–346.PubMedCrossRefGoogle Scholar
  23. 23.
    Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut. 2005;54:v1–v16.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Su Bum Park
    • 1
  • Hyung Wook Kim
    • 1
  • Dae Hwan Kang
    • 1
  • Cheol Woong Choi
    • 1
  • Je Ho Ryu
    • 2
  • Chong Woo Chu
    • 2
  • Soo Yong Lee
    • 1
  • Young Il Jeong
    • 3
  • Hye Ju Yeo
    • 1
  • Eun Jung Kim
    • 1
  1. 1.Department of Internal MedicineSchool of Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan Medical CentersYangsan-siSouth Korea
  2. 2.Department of General SurgerySchool of Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan Medical CentersYangsanKorea
  3. 3.Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan Medical CentersYangsan-siSouth Korea

Personalised recommendations